Stay updated on Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.

Latest updates to the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page's metadata. No study details or data were changed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5 in the footer. This indicates a small update to the page's version metadata and does not affect the study content or user-facing information.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows a new revision label (v3.6.4) replacing the previous (v3.6.3), indicating a background deployment update. No substantive study information or UI content appears to be altered.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, signaling a new published update to the study record. The underlying study data remains unchanged.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page revision indicator was updated from v3.6.0 to v3.6.2. This reflects a software/documentation update rather than changes to trial content.SummaryDifference0.0%

- Check94 days agoChange DetectedThe page now indicates that recruitment has ended for this study. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and includes a minor label formatting change for Intervention/Treatment.SummaryDifference0.4%

Stay in the know with updates to Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.